Patents/Inventors

Jens Hukelmann

TuebingenDE11 patents

12 Patents

US123184072025
Peptides Displayed by HLA for Use in Immunotherapy Against Different Types of Cancers
Immatics Biotechnologies GmbH
0 cites
US122905302025
Peptides Displayed by HLA for Use in Immunotherapy Against Different Types of Cancers
Immatics Biotechnologies GmbH
0 cites
US122854432025
Peptides Displayed by HLA for Use Immunotherapy Against Different Types of Cancers
Immatics Biotechnologies GmbH
0 cites
US122747162025
Peptides Displayed by HLA for Use Immunotherapy Against Different Types of Cancers
Immatics Biotechnologies GmbH
0 cites
US122572692025
Peptides Displayed by HLA for Use in Immunotherapy Against Different Types of Cancers
Immatics Biotechnologies GmbH
0 cites
US122460392025
Peptides Displayed by HLA for Use in Immunotherapy Against Different Types of Cancers
Immatics Biotechnologies GmbH
0 cites
US119694642024
Amidated Peptides and Their Deamidated Counterparts Displayed by HLA-A*02 for Use in Immunotherapy Against Different Types of Cancers
0 cites
US119577162024
Peptides Displayed by HLA for Use in Immunotherapy Against Different Types of Cancers
IMMATICS BIOTECHNOLOGIES GmbH
0 cites
US119524092024
Amidated Peptides and Their Deamidated Counterparts Displayed by Non-hla-a*02 for Use in Immunotherapy Against Different Types of Cancers Preliminary Class
IMMATICS BIOTECHNOLOGIES GmbH
0 cites
US119040032024
Amidated Peptides and Their Deamidated Counterparts Displayed by HLA-A*02 for Use in Immunotherapy Against Different Types of Cancers
Immatics Biotechnologies GmbH
0 cites
US118914272024
Amidated Peptides and Their Deamidated Counterparts Displayed by Non-hla-a*02 for Use in Immunotherapy Against Different Types of Cancers
IMMATICS BIOTECHNOLOGIES GmbH
0 cites
US118331952023
Amidated Peptides and Their Deamidated Counterparts Displayed by HLA-A*02 for Use in Immunotherapy Against Different Types of Cancers
IMMATICS BIOTECHNOLOGIES GmbH
0 cites